NHP Chronic Obstructive Pulmonary Disease (COPD) Model

The Prisys Biotechnologies COPD Model: A Valuable Tool for Studying COPD Pathogenesis

Chronic obstructive pulmonary disease (COPD) is a chronic and progressive lung disease that affects millions of people worldwide. It is most commonly caused by cigarette smoking and is characterized by chronic bronchitis and emphysema, which leads to the narrowing and damage of the airways. The resulting symptoms include coughing, wheezing, and shortness of breath.

The COPD model of Prisys Biotechnologies is an experimental model induced by cigarette smoke of nonhuman primates. This model is designed to mimic the development of human COPD and offers researchers a valuable tool to study the underlying mechanisms of the disease.

The use of bronchoalveolar lavage fluid (BALF) cells differentiation and cytokines, bronchoscopy examinations, radiology X-Ray/CT image, pulmonary function tests, mRNA expression in lung tissue, and inflammatory biomarkers as clinical endpoints allows researchers to assess the efficacy of therapeutic interventions.

The COPD model suggests that the administration of cigarette smoke leads to chronic inflammation and damage of the airways, resulting in impaired lung function similar to what is observed in human COPD. This model provides researchers with a means to study the progression of COPD and develop potential treatments for the disease.

While there is currently no cure for COPD, there are treatments available that can help manage symptoms and slow the progression of the disease. These treatments may include the use of bronchodilators, corticosteroids, oxygen therapy, and pulmonary rehabilitation.

In conclusion, the COPD model of Prisys Biotechnologies is a valuable tool for researchers to study the pathogenesis of COPD and develop potential treatments for the disease. Ongoing research into the underlying mechanisms of the disease offers hope for future treatment options for patients with this debilitating condition.

Clinical endpoint:

• Bronchoalveolar lavage fluid (BALF) cells differentiation and cytokines
• Bronchoscopy examinations
• Radiology X-Ray/CT image: lung/chest
• Pulmonary Function Test etc.
• Additional endpoints: mRNA expression in lung tissue, Inflammatory Biomarkers etc.

Hot Tags: nhp chronic obstructive pulmonary disease (copd) model, research, study, monkey, gene therapy, antibody PD pharmacology, Psoriasis Nonhuman Primates, PD pharmacology, Uveitis Nonhuman Primates Disease Model, NHP CRO pharmacology, Multiple Sclerosis Nonhuman Primates